EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

The prescribing of cardioprotective medications and the impact on survival for patients with peripheral artery disease that undergo intervention

Odette Hart iD, Nicole Xue, Manar Khashram iD

ANZ Journal of Surgery · 2023

DOI: 10.1111/ans.18580 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift ANZ Journal of Surgery, 2023. Verfasst von Odette Hart und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, The University of Auckland, Auckland, New Zealand. Hauptthemen laut MEDLINE: Antihypertensive Agents, Peripheral Arterial Disease, Platelet Aggregation Inhibitors, Hypolipidemic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Reg Worcester Research Scholarship 2023, Professor Philip Walker Vascular Surgery Research Scholarship 2022 and 2021, Royal Australasian College of Surgeons and the Foundation for Surgery.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cardiovascular disease guidelines recommend that patients with established peripheral artery disease (PAD) are prescribed antihypertensive, lipid‐lowering, and antiplatelet medication to reduce cardiovascular ischaemic events. However, the prescribing of these medications for patients with PAD within New Zealand (NZ) remains undefined.

Methods

This was a retrospective observational cohort study of patients in the Midland region of NZ, that underwent PAD‐related percutaneous and surgical intervention between 1st January 2010 and 31st December 2021. Patient level data was collected. The primary outcome was prescribing of cardioprotective medications either before or within 1 year of incident procedure. Secondary outcome was overall survival.

Results

There were 2547 patients included. Antihypertensive prescription occurred in 80.7%, lipid‐lowering in 77.4% and antithrombotic in 89.9%. Concomitant ischaemic heart disease increased prescription of cardioprotective medications. Women were prescribed less lipid‐lowering medication compared to men. Māori men were prescribed less antiplatelet medication compared to non‐Māori men. On univariate analysis lipid‐lowering and antiplatelet medication showed survival advantage, while antihypertensive and anticoagulation did not. After adjustment for age, sex, end stage renal failure and presence of chronic limb‐threatening ischaemia, best medical therapy was associated with better survival (HR 0.88, 95% CI 0.79–0.98, P = 0.02).

Conclusion

This study highlights areas of deficiency in prescribing of cardioprotective medication in this high‐risk group. These could be targets for national quality improvement initiatives.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antihypertensive AgentsPeripheral Arterial DiseasePlatelet Aggregation InhibitorsHypolipidemic AgentsFemaleHumansMaleCohort StudiesLipidsMaori PeopleRisk FactorsTreatment OutcomeCardiovascular AgentsRetrospective StudiesAustralasian PeopleProtective AgentsCardiovascular DiseasesIschemia

Stichwörter der Autor:innen

chronic limb-threatening ischemiaepidemiologyintermittent claudicationperipheral artery disease

Substanzen

Antihypertensive AgentsLipidsPlatelet Aggregation InhibitorsHypolipidemic AgentsCardiovascular AgentsProtective Agents

Autor:innen und Institutionen

  • Department of Surgery, The University of Auckland, Auckland, New Zealand.
  • Department of Vascular Surgery, Waikato District Health Board, Hamilton, New Zealand.

ORCID-Profile: Odette Hart, Manar Khashram

Förderung

  • Reg Worcester Research Scholarship 2023
  • Professor Philip Walker Vascular Surgery Research Scholarship 2022 and 2021
  • Royal Australasian College of Surgeons and the Foundation for Surgery

Zitieren

APA

Hart, O., Xue, N., & Khashram, M. (2023). The prescribing of cardioprotective medications and the impact on survival for patients with peripheral artery disease that undergo intervention. ANZ Journal of Surgery. https://doi.org/10.1111/ans.18580

Vancouver

Hart O, Xue N, Khashram M. The prescribing of cardioprotective medications and the impact on survival for patients with peripheral artery disease that undergo intervention. ANZ Journal of Surgery. 2023. doi:10.1111/ans.18580

BibTeX
@article{Hart2023,
  author = {Hart, Odette and Xue, Nicole and Khashram, Manar},
  title = {The prescribing of cardioprotective medications and the impact on survival for patients with peripheral artery disease that undergo intervention},
  journal = {ANZ Journal of Surgery},
  year = {2023},
  doi = {10.1111/ans.18580}
}
Kostenlos starten →